Assessment of the Watchman Device in Patients Unsuitable for Oral Anticoagulation (ASAP-TOO)

General Information

Age Group



Active, not recruiting

Protocol Number


Background Information

The ASAP-TOO study is a prospective, randomized, multi-center, global investigation to establish the safety and effectiveness of the Watchman Device for subjects with non-valvular atrial fibrillation who are deemed not suitable for anti-coagulation therapy to reduce the risk of stroke. Subjects are randomized in a ratio of 2 device to 1 control to receive the Watchman LAA closure device or the control treatment of single antiplatelet medication or no medication at the discretion of the study physician.

Offered At

Inova Fairfax Hospital
3300 Gallows Rd.
Falls Church, VA 22042

Principal Investigator